Table 1.
Demographic features of patients and controls
| RA-TNF1 (n = 38) | RA-TNF2 (n = 38) | TNF-naive RA (n = 40) |
TB (n = 30) |
Leprosy (n = 23) |
Healthy controls (n = 41) |
|
|---|---|---|---|---|---|---|
| F:M | 31:7 | 31:7 | 29:11 | 21:9 | 7:16 | 29:12 |
| Mean age (years) | 51.7 ± 14.2 | 51.7 ± 14.2 | 52.6 ± 13.5 | 43.0 ± 13.4 | 57.1 ± 9.6 | 41.1 ± 12.1 |
| BCG scar (+) | 24 | 24 | 25 | 23 | 16 | 27 |
| QTF | ||||||
| (+) | 13 (34%) | 16 (42%) | 20 (50%) | 15 (50%) | 14 (61%) | 19 (47%) |
| (-) | 23 (61%) | 22 (58%) | 19 (47%) | 13 (43%) | 8 (35%) | 22 (53%) |
| Indeterminate | 2 (5%) | 0 | 1 (3%) | 2 (7%) | 1 (4%) | 0 |
| TST | ||||||
| 10 mm (+) | 9 (24%) | 14 (37%) | 22 (55%) | 17 (57%) | 13 (57%) | 28 (68%) |
| 5 mm (+) | 10 (26%) | 17 (45%) | 24 (60%) | 21 (70%) | 14 (61%) | 33 (80%) |
Results in rheumatoid arthritis patients before (RA-TNF1) and after (RA-TNF2) treatment with TNF-α antagonists, rheumatoid arthritis patients who were not prescribed TNF-α antagonists (TNF-naive RA), rheumatology patients who had current or past confirmed tuberculosis infection (TB), leprosy patients, and healthy controls.